Microfluidics Device Market – Industry Analysis and Forecast (2019 to 2026) By Application, Component (Type & Material), and Region

Microfluidics Device Market was valued at USD 8.25 billion in 2019, and is estimated to grow at a CAGR of XX % from 2018 to 2026. The report includes the analysis of impact of COVID-19 lock-down on the revenue of market leaders, followers, and disrupters. Since lock down was implemented differently in different regions and countries, impact of same is also different by regions and segments. The report has covered the current short term and long term impact on the market, same will help decision makers to prepare the outline for short term and long term strategies for companies by region. To know about the Research Methodology :- Request Free Sample Report Microfluidic devices exploit the physical and chemical properties of liquids and gases at the microscopic scale. It offers many advantages over conventional sized systems. It helps to perform many operations at the same time because of their compact size, thereby shortening the time of the experiment. It also has excellent data quality and important parameter control that automates the process, while preserving performance. Some of the market drivers for the Microfluidics Device Market include increased demand for POC testing, benefits associated with incorporation of microfluidics across different industries, higher return on investments as well as technological advancements. The microfluidics market is segmented by application, component (type & material), and region. The Microfluidics Device Market is fragmented into instruments, microfluidics, cartridges, and reagents, among others. Of these, cartridges and reagents held a significant share of the global market and the segment is expected to continue to dominate in the coming years. In terms of turnover, the Microfluidics Device Market accounted for 45.2% of the global market in 2016. The considerable acceptance of microfluidic products in laboratories and industries has provided cartridges and reagents with this wide margin of growth. The report predicts that instruments and microfluidic chip segments will closely follow the runway during the forecast period. Geographically, Asia-Pacific is expected to grow successfully in the coming years. It may be attributed to the growing mergers and acquisitions and technological advances in emerging countries. However, North America accounted for the largest share in 2017. The growing adoption of microfluidic technology and the continued roll-out of new products in the North American region are the few factors driving market growth for Microfluidics Device Market. The key players in the Microfluidics Device Market include Danaher (US), Thermo Fisher (US), PerkinElmer (US), Agilent (US), Bio-Rad (US), Becton, Dickinson and Company (US), Roche (Switzerland), Illumina (US), Fluidigm, Microfluidics (US), and QIAGEN (Netherlands). OGYROS PROTEIN TECHNOLOGIES AB (Sweden), Sphere Fluidics (UK), OPKO Health (US), Waters (US), thinXXS Microtechnology (Germany), Abaxis (US), bioMérieux (France), Abbott (US), Dolomite Microfluidics (UK), Microfluidic ChipShop (Germany), Elveflow (France), Cellix (Ireland), Micronit Microtechnologies (Netherlands), MicroLiquid (Spain), MiniFAB (Australia), uFluidix (Canada), Micralyne (US), and Fluigent (France). The objective of the report is to present comprehensive Microfluidics Device Market  including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Microfluidics Device Market  North America for Asia Pacific dynamics, structure by analyzing the market segments, and project the Microfluidics Device Market  North America for Asia Pacific   size. Clear representation of competitive analysis of key players by type, price, financial position, product portfolio, growth strategies, and regional presence in the Microfluidics Device Market  North America for Asia Pacific make the report investor’s guide.

The years that have been considered for the study are:

• Base year – 2016 • Estimated year – 2017 • Forecast period – 2017 to 2024 Target Audience: • Microfluidics-based product manufacturers & distributors • Microfluidic component manufacturers • Pharmaceutical and diagnostic companies • Research institutes • Medical device companies • Life science companies • Healthcare institutions (hospitals, medical schools, and outpatient clinics) • Government associations • Market research and consulting firms • Venture capitalists and investors

Scope Of The Microfluidics Device Market :Inquire before buying

Microfluidics Device Market, By Application:

• In vitro diagnostics o Point-of-care Testing o Clinical Diagnostics • Pharmaceutical research    o Lab analytics  Proteomic Analysis  Genomic Analysis  Cell-based Assay  Capillary Electrophoresis   o Micropispensing   o Microreaction • Drug Delivery • Laboratory Testing o Agro food Testing o Industrial Testing o Environmental Testing

Microfluidics Device Market, By Type

• Microfluidic Chips • Microfluidic Sensors • Microfluidic Pumps • Microneedles • Other Component (Flow Controller, Temperature controller, connectors, droplet generator, microreactors, and valves)

Microfluidics Device Market, By Material

• Polymer-based Microfluidics • Glass-based Microfluidics • Silicone-based Microfluidics • Other material-based Microfluidics (Paper, Ceramics, & Metal)

Microfluidics Device Market, Company Profiles

• Danaher (US) • Thermo Fisher (US) • PerkinElmer (US) • Agilent (US) • Bio-Rad (US) • Becton • Dickinson and Company (US) • Roche (Switzerland) • Illumina (US) • Fluidigm • Microfluidics (US) • QIAGEN (Netherlands) • OGYROS PROTEIN TECHNOLOGIES AB (Sweden) • Sphere Fluidics (UK) • OPKO Health (US) • Waters (US) • thinXXS Microtechnology (Germany) • Abaxis (US) • bioMérieux (France) • Abbott (US) • Dolomite Microfluidics (UK) • Microfluidic ChipShop (Germany) • Elveflow (France) • Cellix (Ireland) • Micronit Microtechnologies (Netherlands) • MicroLiquid (Spain) • MiniFAB (Australia) • uFluidix (Canada) • Micralyne (US) • Fluigent (France).

Microfluidics Device Market, By Region

North America • U.S • Canada Europe • Germany • France • UK • Italy • Spain • Russia • Rest of Europe Asia Pacific • Japan • China • India • South Korea • Australia • Rest of Asia Pacific Rest of the World (ROW): • Middle-East • Africa • Latin America

Microfluidics Device Market

1. INTRODUCTION 1.1. Market description & Scope (2019-2026) 1.2. Objectives 1.2.1. Key Takeaways 1.2.2. Abbreviations & Acronyms 2. RESEARCH METHODOLOGY 2.1. Methods used for market forecasting 2.2. Data 2.2.1. Paid 2.2.2. Primary 2.2.3. Secondary 3. EXECUTIVE SUMMARY 3.1. Major Findings 3.1.1. Key Segment Trends 3.1.1.1. Application 3.1.1.2. Type 3.1.1.3. Material 3.1.2. Key Regional Trends 3.1.2.1. North America 3.1.2.2. Europe 3.1.2.3. Asia Pacific 3.1.2.4. Rest of the World 3.2. Key Companies and their Strategies 4. MARKET OVERVIEW 4.1. Microfluidics Device Market Concept & Definition 4.2. Segments Overview 4.2.1. By Application 4.2.1.1. In vitro diagnostics 4.2.1.1.1. Point-of-care Testing 4.2.1.1.2. Clinical Diagnostics 4.2.1.2. Pharmaceutical research 4.2.1.2.1. Lab analytics 4.2.1.2.1.1. Proteomic Analysis 4.2.1.2.1.2. Genomic Analysis 4.2.1.2.1.3. Cell-based Assay 4.2.1.2.1.4. Capillary Electrophoresis 4.2.1.2.2. Micropispensing 4.2.1.2.3. Microreaction 4.2.1.3. Drug Delivery 4.2.1.4. Laboratory Testing 4.2.1.4.1. Agro food Testing 4.2.1.4.2. Industrial Testing 4.2.1.4.3. Environmental Testing 4.2.2. By Type 4.2.2.1. Microfluidic Chips 4.2.2.2. Microfluidic Sensors 4.2.2.3. Microfluidic Pumps 4.2.2.4. Microneedles 4.2.2.5. Other Component 4.2.3. By Material 4.2.3.1. Polymer-based Microfluidics 4.2.3.2. Glass-based Microfluidics 4.2.3.3. Silicone-based Microfluidics 4.2.3.4. Other material-based Microfluidics (Paper, Ceramics, & Metal) 4.2.4. Market Dynamics 4.2.4.1. Drivers 4.2.4.2. Restraints 4.2.4.3. Opportunities 4.3. Porter’s Analysis 4.4. PESTLE Analysis 4.5. Fragmentation 4.5.1. Key strategic Alliances of companies (inorganic & organic) 4.5.2. Company Market Share (Top 10 Players) 4.5.3. Comparative Analysis of Key players in Recycled Plastics 4.6. Key Trends 4.7. Key Trends in Global Microfluidics Device Market 5. MICROFLUIDICS DEVICE MARKET TYPE & ESTIMATE TREND ANALYSIS (2019-2026) 5.1. Microfluidics Device Market Type Analysis 5.1.1. Microfluidic Chips 5.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 5.1.2. Microfluidic Sensors 5.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 5.1.3. Microfluidic Pumps 5.1.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 5.1.4. Microneedles 5.1.4.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 5.1.5. Other Component 5.1.5.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 5.2. Microfluidics Device Market: Product Trends 6. MICROFLUIDICS DEVICE MARKET MATERIAL ESTIMATES & TREND ANALYSIS (2019-2026) 6.1. Microfluidics Device Market Material Market Analysis 6.1.1. Polymer-based Microfluidics 6.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.2. Glass-based Microfluidics 6.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.3. Silicone-based Microfluidics 6.1.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 6.1.4. Other material-based Microfluidics 6.2. Microfluidics Market Device Market Material Trends 7. MICROFLUIDICS DEVICE MARKET APPLICATION ESTIMATES & TREND ANALYSIS (2019-2026) 7.1. Microfluidics Device Market Application Market Analysis 7.1.1. In Vitro Diagnostics 7.1.1.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.2. Pharmaceutical Research 7.1.2.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.3. Drug Delivery 7.1.3.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.1.4. Laboratory Testing 7.1.4.1. Market Share and growth forecasts, 2019-2026 (USD Billion) 7.2. Microfluidics Device Market: Application Trends 8. REGIONAL ESTIMATES & TREND ANALYSIS (2019-2026) 8.1. Microfluidics Device Market share by Region, 2016 & 2025 8.2. North America 8.2.1. North America Microfluidics Device Market, Market Share and growth forecasts, 2019-2026 (USD Billion) 8.2.2. Microfluidics Device Market Drivers For North America Market 8.2.3. Market Share Analysis and Growth Forecast, by Country 8.2.3.1. US 8.2.3.2. Canada 8.2.4. Country-wise GDP Growth Forecast 8.2.5. Microfluidics Device Market Trends In North America Market 8.3. Europe 8.3.1. Europe Microfluidics Device Market, Market Share and growth forecasts, 2019-2026 (USD Billion) 8.3.2. Microfluidics Device Market Drivers For Europe Market 8.3.3. Market Share Analysis and Growth Forecast, by Country 8.3.3.1. UK 8.3.3.2. Germany 8.3.3.3. France 8.3.3.4. Russia 8.3.3.5. Spain 8.3.3.6. Italy 8.3.3.7. Others 8.3.4. Country-wise GDP Growth Forecast 8.3.5. Microfluidics Device Market Trends In Europe Market 8.4. Asia Pacific 8.4.1. Asia Pacific Microfluidics Market Device Market, Market Share and growth forecasts, 2019-2026 (USD Billion) 8.4.2. Microfluidics Device Market Drivers For Asia Pacific Market 8.4.3. Market Share Analysis and Growth Forecast, by Country 8.4.3.1. China 8.4.3.2. Japan 8.4.3.3. India 8.4.3.4. South Korea 8.4.3.5. Australia 8.4.3.6. Others 8.4.4. Country-wise GDP Growth Forecast 8.4.5. Microfluidics Device Market Trends In Asia Pacific Market 8.5. Rest of the World 8.5.1. Rest of the World Market Microfluidics Device Market, Share and growth forecasts, 2019-2026 (USD Billion) 8.5.2. Microfluidics Device Market Drivers For Rest of the World Market 8.5.3. Market Share Analysis and Growth Forecast, by Country 8.5.3.1. Middle-East 8.5.3.2. Africa 8.5.3.3. Latin America 8.5.4. Country-wise GDP Growth Forecast 8.5.5. Microfluidics Device Market Trends In Rest of the World Market 9. MARKET SHARE ANALYSIS 9.1. Key Players Regional Market share Analysis 9.1.1. North America 9.1.2. Europe 9.1.3. Asia Pacific 9.1.4. Middle-east 9.1.5. Latin America 10. MARKET COMPETITION ANALYSIS 10.1. Strategy Framework 10.2. Consolidation 10.2.1. Patent Analysis 10.2.2. Mergers & Acquisitions 10.2.2.1. Product Based 10.2.2.2. Services Based 10.2.2.3. Region Based 10.2.2.4. List of Mergers & Acquisitions 10.2.3. Company Benchmarking (Revenue & Profit Based) 10.2.4. Strategic Assessment of Company Consolidations 10.2.5. Emerging Business Models 10.3. Company Profiles 10.3.1. Danaher 10.3.1.1. Company overview 10.3.1.2. Key financials 10.3.1.3. Geographical presence 10.3.1.4. Product and Business Segments 10.3.1.5. Strategic initiatives 10.3.1.6. SWOT analysis 10.3.1.7. Competitive positioning and landscape 10.3.2. Thermo Fisher 10.3.2.1. Company overview 10.3.2.2. Key financials 10.3.2.3. Geographical presence 10.3.2.4. Product and Business Segments 10.3.2.5. Strategic initiatives 10.3.2.6. SWOT analysis 10.3.2.7. Competitive positioning and landscape 10.3.3. PerkinElmer 10.3.3.1. Company overview 10.3.3.2. Key financials 10.3.3.3. Geographical presence 10.3.3.4. Product and Business Segments 10.3.3.5. Strategic initiatives 10.3.3.6. SWOT analysis 10.3.3.7. Competitive positioning and landscape 10.3.4. Agilent 10.3.4.1. Company overview 10.3.4.2. Key financials 10.3.4.3. Geographical presence 10.3.4.4. Product and Business Segments 10.3.4.5. Strategic initiatives 10.3.4.6. SWOT analysis 10.3.4.7. Competitive positioning and landscape 10.3.5. Bio-Rad 10.3.5.1. Company overview 10.3.5.2. Key financials 10.3.5.3. Geographical presence 10.3.5.4. Product and Business Segments 10.3.5.5. Strategic initiatives 10.3.5.6. SWOT analysis 10.3.5.7. Competitive positioning and landscape 10.3.6. Becton 10.3.6.1. Company overview 10.3.6.2. Key financials 10.3.6.3. Geographical presence 10.3.6.4. Product and Business Segments 10.3.6.5. Strategic initiatives 10.3.6.6. SWOT analysis 10.3.6.7. Competitive positioning and landscape 10.3.7. Dickinson and Company 10.3.7.1. Company overview 10.3.7.2. Key financials 10.3.7.3. Geographical presence 10.3.7.4. Product and Business Segments 10.3.7.5. Strategic initiatives 10.3.7.6. SWOT analysis 10.3.7.7. Competitive positioning and landscape 10.3.8. Roche 10.3.8.1. Company overview 10.3.8.2. Key financials 10.3.8.3. Geographical presence 10.3.8.4. Product and Business Segments 10.3.8.5. Strategic initiatives 10.3.8.6. SWOT analysis 10.3.8.7. Competitive positioning and landscape 10.3.9. Illumina 10.3.9.1. Company overview 10.3.9.2. Key financials 10.3.9.3. Geographical presence 10.3.9.4. Product and Business Segments 10.3.9.5. Strategic initiatives 10.3.9.6. SWOT analysis 10.3.9.7. Competitive positioning and landscape 10.3.10. Fluidigm 10.3.10.1. Company overview 10.3.10.2. Key financials 10.3.10.3. Geographical presence 10.3.10.4. Product and Business Segments 10.3.10.5. Strategic initiatives 10.3.10.6. SWOT analysis 10.3.10.7. Competitive positioning and landscape 10.3.11. Microfluidics 10.3.11.1. Company overview 10.3.11.2. Key financials 10.3.11.3. Geographical presence 10.3.11.4. Product and Business Segments 10.3.11.5. Strategic initiatives 10.3.11.6. SWOT analysis 10.3.11.7. Competitive positioning and landscape 10.3.12. QIAGEN 10.3.12.1. Company overview 10.3.12.2. Key financials 10.3.12.3. Geographical presence 10.3.12.4. Product and Business Segments 10.3.12.5. Strategic initiatives 10.3.12.6. SWOT analysis 10.3.12.7. Competitive positioning and landscape 10.3.13. OGYROS PROTEIN TECHNOLOGIES AB 10.3.13.1. Company overview 10.3.13.2. Key financials 10.3.13.3. Geographical presence 10.3.13.4. Product and Business Segments 10.3.13.5. Strategic initiatives 10.3.13.6. SWOT analysis 10.3.13.7. Competitive positioning and landscape 10.3.14. Sphere Fluidics 10.3.14.1. Company overview 10.3.14.2. Key financials 10.3.14.3. Geographical presence 10.3.14.4. Product and Business Segments 10.3.14.5. Strategic initiatives 10.3.14.6. SWOT analysis 10.3.14.7. Competitive positioning and landscape 10.3.15. OPKO Health 10.3.15.1. Company overview 10.3.15.2. Key financials 10.3.15.3. Geographical presence 10.3.15.4. Product and Business Segments 10.3.15.5. Strategic initiatives 10.3.15.6. SWOT analysis 10.3.15.7. Competitive positioning and landscape 10.3.16. Waters 10.3.16.1. Company overview 10.3.16.2. Key financials 10.3.16.3. Geographical presence 10.3.16.4. Product and Business Segments 10.3.16.5. Strategic initiatives 10.3.16.6. SWOT analysis 10.3.16.7. Competitive positioning and landscape 10.3.17. thinXXS Microtechnology 10.3.17.1. Company overview 10.3.17.2. Key financials 10.3.17.3. Geographical presence 10.3.17.4. Product and Business Segments 10.3.17.5. Strategic initiatives 10.3.17.6. SWOT analysis 10.3.17.7. Competitive positioning and landscape 10.3.18. Abaxis 10.3.18.1. Company overview 10.3.18.2. Key financials 10.3.18.3. Geographical presence 10.3.18.4. Product and Business Segments 10.3.18.5. Strategic initiatives 10.3.18.6. SWOT analysis 10.3.18.7. Competitive positioning and landscape 10.3.19. bioMérieux 10.3.19.1. Company overview 10.3.19.2. Key financials 10.3.19.3. Geographical presence 10.3.19.4. Product and Business Segments 10.3.19.5. Strategic initiatives 10.3.19.6. SWOT analysis 10.3.19.7. Competitive positioning and landscape 10.3.20. Abbott 10.3.20.1. Company overview 10.3.20.2. Key financials 10.3.20.3. Geographical presence 10.3.20.4. Product and Business Segments 10.3.20.5. Strategic initiatives 10.3.20.6. SWOT analysis 10.3.20.7. Competitive positioning and landscape 10.3.21. Dolomite Microfluidics 10.3.21.1. Company overview 10.3.21.2. Key financials 10.3.21.3. Geographical presence 10.3.21.4. Product and Business Segments 10.3.21.5. Strategic initiatives 10.3.21.6. SWOT analysis 10.3.21.7. Competitive positioning and landscape 10.3.22. Microfluidic ChipShop 10.3.22.1. Company overview 10.3.22.2. Key financials 10.3.22.3. Geographical presence 10.3.22.4. Product and Business Segments 10.3.22.5. Strategic initiatives 10.3.22.6. SWOT analysis 10.3.22.7. Competitive positioning and landscape 10.3.23. Elveflow 10.3.23.1. Company overview 10.3.23.2. Key financials 10.3.23.3. Geographical presence 10.3.23.4. Product and Business Segments 10.3.23.5. Strategic initiatives 10.3.23.6. SWOT analysis 10.3.23.7. Competitive positioning and landscape 10.3.24. Cellix 10.3.24.1. Company overview 10.3.24.2. Key financials 10.3.24.3. Geographical presence 10.3.24.4. Product and Business Segments 10.3.24.5. Strategic initiatives 10.3.24.6. SWOT analysis 10.3.24.7. Competitive positioning and landscape 10.3.25. Micronit Microtechnologies 10.3.25.1. Company overview 10.3.25.2. Key financials 10.3.25.3. Geographical presence 10.3.25.4. Product and Business Segments 10.3.25.5. Strategic initiatives 10.3.25.6. SWOT analysis 10.3.25.7. Competitive positioning and landscape 10.3.26. MicroLiquid (Spain) 10.3.26.1. Company overview 10.3.26.2. Key financials 10.3.26.3. Geographical presence 10.3.26.4. Product and Business Segments 10.3.26.5. Strategic initiatives 10.3.26.6. SWOT analysis 10.3.26.7. Competitive positioning and landscape 10.3.27. MiniFAB 10.3.27.1. Company overview 10.3.27.2. Key financials 10.3.27.3. Geographical presence 10.3.27.4. Product and Business Segments 10.3.27.5. Strategic initiatives 10.3.27.6. SWOT analysis 10.3.27.7. Competitive positioning and landscape 10.3.28. uFluidix 10.3.28.1. Company overview 10.3.28.2. Key financials 10.3.28.3. Geographical presence 10.3.28.4. Product and Business Segments 10.3.28.5. Strategic initiatives 10.3.28.6. SWOT analysis 10.3.28.7. Competitive positioning and landscape 10.3.29. Micralyne 10.3.29.1. Company overview 10.3.29.2. Key financials 10.3.29.3. Geographical presence 10.3.29.4. Product and Business Segments 10.3.29.5. Strategic initiatives 10.3.29.6. SWOT analysis 10.3.29.7. Competitive positioning and landscape 10.3.30. Fluigent 10.3.30.1. Company overview 10.3.30.2. Key financials 10.3.30.3. Geographical presence 10.3.30.4. Product and Business Segments 10.3.30.5. Strategic initiatives 10.3.30.6. SWOT analysis 10.3.30.7. Competitive positioning and landscape

About This Report

Report ID 11038
Category Healthcare
Published Date oct 2019
Updated Date Dec 2020
Contact Us